A convenient protonated strategy for constructing nanodrugs from hydrophobic drug-inhibitor conjugates to reverse tumor multidrug resistance

A novel nanodrug constructed from hydrophobic drug-inhibitor conjugates through a protonated strategy to synergistically reverse MDR and inhibit tumor growth.